Managing SARS-CoV2 Infections Through Resolution of Inflammation by Eicosanoids: A Review

References

• Ciotti M, Angeletti S, Minieri M, et al. COVID-19 outbreak: an overview. Chemotherapy. 2019;64(5–6):215–223. PMID: 32259829; PMCID: PMC7179549. doi:10.1159/000507423
   PubMed Web of Science ®Google Scholar
• Khan M, Adil SF, Alkhathlan HZ, et al. COVID-19: a global challenge with old history, epidemiology and progress so far. Molecules. 2020;26(1):39. PMID: 33374759; PMCID: PMC7795815. doi:10.3390/molecules26010039
   PubMed Web of Science ®Google Scholar
• Tang Y, Liu J, Zhang D, Xu Z, Ji J, Wen C. Cytokine storm in COVID-19: the current evidence and treatment strategies. Front Immunol. 2020;11:1708. PMID: 32754163; PMCID: PMC7365923. doi:10.3389/fimmu.2020.01708
   PubMed Web of Science ®Google Scholar
• Beyerstedt S, Casaro EB, Rangel ÉB. COVID-19: angiotensin-converting enzyme 2 (ACE2) expression and tissue susceptibility to SARS-CoV-2 infection. Eur J Clin Microbiol Infect. 2021;Dis40:905–919. doi:10.1007/s10096-020-04138-6
   Web of Science ®Google Scholar
• Anka AU, Tahir MI, Abubakar SD, et al. Coronavirus disease 2019 (COVID-19): an overview of the immunopathology, serological diagnosis and management. Scand J Immunol. 2021;93(4):e12998. PMID: 33190302; PMCID: PMC7744910. doi:10.1111/sji.12998
   PubMed Web of Science ®Google Scholar
• Hannoodee S, Nasuruddin DN. Acute Inflammatory Response. StatPearls Publishing; 2022. Bookshelf ID: NBK556083, PMID: 32310543.
   Google Scholar
• Pahwa R, Goyal A, Jialal I. Chronic Inflammation. StatPearls Publishing; 2022. Bookshelf ID: NBK493173, PMID: 29630225.
   Google Scholar
• Larsen GL, Henson PM. Mediators of inflammation. Annu Rev Immunol. 1983;1:335–359. PMID: 6399978. doi:10.1146/annurev.iy.01.040183.002003
   PubMed Web of Science ®Google Scholar
• Calder PC, Harwood J, Lloyd-Evans E. Eicosanoids. Essays Biochem. 2020;64(3):423–441. PMID: 32808658. doi:10.1042/EBC20190083
   PubMed Web of Science ®Google Scholar
• Robert C, Rebecca C, Dickinson J, Berry Z. Perspectives on the biosynthesis and metabolism of eicosanoids. Eicosanoids. 2004;1–16. doi:10.1002/0470020628.ch1
   Google Scholar
• Khanapure SP, Garvey DS, Janero DR, Letts LG. Eicosanoids in inflammation: biosynthesis, pharmacology, and therapeutic frontiers. Curr Top Med Chem. 2007;7:311–340. doi:10.2174/156802607779941314
   PubMed Web of Science ®Google Scholar
• Freire MO, Van Dyke TE. Natural resolution of inflammation. Periodontol 2000. 2013;63:149–164. doi:10.1111/prd.12034
   PubMed Web of Science ®Google Scholar
• Werder RB, Lynch JP, Simpson JC, Zhang V, Nick H. PGD2/DP2 receptor activation promotes severe viral bronchiolitis by suppressing IFN- production. Sci Transl Med. 2018;10(440). doi:10.1126/scitranslmed.aao0052
   PubMed Web of Science ®Google Scholar
• Takahisa MURATA, Toko MAEHARA. Discovery of anti-inflammatory role of prostaglandin D 2. J Vet Med Sci. 2016;78(11):1643–1647. doi:10.1292/jvms
   PubMed Web of Science ®Google Scholar
• Murata T, Aritake K, Tsubosaka Y, et al. Anti-inflammatory role of PGD2 in acute lung inflammation and therapeutic application of its signal enhancement. Proce Nat Acad Sci. 2013;110(13):5205–5210. doi:10.1073/pnas.1218091110
   PubMed Web of Science ®Google Scholar
• Umamaheswaran S, Dasari SK, Yang P, Lutgendorf SK, Sood AK. Stress, inflammation, and eicosanoids: an emerging perspective. Cancer Metastasis Rev. 2018;37:203–211. doi:10.1007/s10555-018-9741-1
   PubMed Web of Science ®Google Scholar
• Basil MC, Levy BD. Specialized pro-resolving mediators: endogenous regulators of infection and inflammation. Nat Rev Immunol. 2016;16:51–67. doi:10.1038/nri.2015.4
   PubMed Web of Science ®Google Scholar
• Rossi A, Sawatzky DA. The Resolution of Inflammation. Springer Science & Business Media; 2008.
   Google Scholar
• Serhan CN, Chiang N, Van Dyke TE. Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat Rev Immunol. 2008;8:349–361. doi:10.1038/nri2294
   PubMed Web of Science ®Google Scholar
• Nore KG, Jørgensen MJ, Dyrhol-Riise AM, Jenum S, Tonby K. Elevated levels of anti-inflammatory eicosanoids and monocyte heterogeneity in mycobacterium tuberculosis infection and disease. Front Immunol. 2020;12(11):579849. doi:10.3389/fimmu.2020.579849
   Web of Science ®Google Scholar
• Ricke-Hoch M, Stelling E, Lisa Lasswitz AP, et al. Impaired immune response mediated by prostaglandin E2 promotes severe COVID-19 disease. PLoS One. 2021;16(8):e0255335. doi:10.1371/journal.pone.0255335
   PubMed Web of Science ®Google Scholar
• Cheng Y, Austin SC, Bianca Rocca BH, et al. Role of prostacyclin in the cardiovascular response to thromboxane A2. Science. 2002;296(5567):539–541. doi:10.1126/science.1068711
   PubMed Web of Science ®Google Scholar
• Zouein FA, Altara R, Booz GW. Immunomodulatory Approaches in Cardiovascular Diseases. Frontiers Media SA; 2022.
   Google Scholar
• Ricciotti E, FitzGerald GA. Prostaglandins and Inflammation. Arterioscler Thromb Vasc Biol. 2011;31(5):986–1000. doi:10.1161/ATVBAHA.110.207449
   PubMed Web of Science ®Google Scholar
• Sharma A, Ahmad Farouk I, Lal SK. COVID-19: a review on the novel coronavirus disease evolution, transmission, detection, control and prevention. Viruses. 2021;13(2):202. PMID: 33572857; PMCID: PMC7911532. doi:10.3390/v13020202
   PubMed Web of Science ®Google Scholar
• Calder P. Polyunsaturated fatty acids and inflammation: therapeutic potential in rheumatoid arthritis. Curr Rheumatol Rev. 2009;5:214–225. doi:10.2174/157339709790192558
   Google Scholar
• Ichiyama T, Kajimoto M, Hasegawa M, Hashimoto K, Matsubara T, Furukawa S. Cysteinyl leukotrienes enhance tumour necrosis factor-alpha-induced matrix metalloproteinase-9 in human monocytes/macrophages. Clin Exp Allergy. 2007;37(4):608–614. PMID: 17430359. doi:10.1111/j.1365-2222.2007.02692.x
   PubMed Web of Science ®Google Scholar
• Serhan CN. Pro-resolving lipid mediators are leads for resolution physiology. Nature. 2014;510(7503):92–101. PMID: 24899309; PMCID: PMC4263681. doi:10.1038/nature13479
   PubMed Web of Science ®Google Scholar
• Samuelsson B, Dahlen S, Lindgren J, Rouzer C, Serhan C. Leukotrienes and lipoxins: structures, biosynthesis, and biological effects. Science. 1987;237:1171–1176. doi:10.1126/science.2820055
   PubMed Web of Science ®Google Scholar
• Bannenberg GL, Chiang N, Ariel A, et al. Molecular circuits of resolution: formation and actions of resolvins and protectins. J Immunol. 2005;174(7):4345–4355. PMID: 15778399. doi:10.4049/jimmunol.174.7.4345
   PubMed Web of Science ®Google Scholar
• Campbell EL, Louis NA, Tomassetti SE, et al. Resolvin E1 promotes mucosal surface clearance of neutrophils: a new paradigm for inflammatory resolution. FASEB J. 2007;21(12):3162–3170. PMID: 17496159. doi:10.1096/fj.07-8473com
   PubMed Web of Science ®Google Scholar
• Serhan CN. Systems approach to inflammation resolution: identification of novel anti-inflammatory and pro-resolving mediators. J Thromb Haemost. 2009;7:44–48. doi:10.1111/j.1538-7836.2009.03396.x
   PubMed Web of Science ®Google Scholar
• Panigrahy D, Gilligan MM, Huang S, et al. Inflammation resolution: a dual-pronged approach to averting cytokine storms in COVID-19? Cancer Metastasis Rev. 2020;39(2):337–340. PMID: 32385712; PMCID: PMC7207990. doi:10.1007/s10555-020-09889-4
   PubMed Web of Science ®Google Scholar
• Serhan CN, Chiang N. Endogenous pro-resolving and anti-inflammatory lipid mediators: a new pharmacologic genus. Br J Pharmacol. 2008;153:S200–S215. doi:10.1038/sj.bjp.0707489
   PubMed Web of Science ®Google Scholar
• Asatryan A, Bazan NG. Molecular mechanisms of signaling via the docosanoid neuroprotectin D1 for cellular homeostasis and neuroprotection. J Biol Chem. 2017;292:12390–12397. doi:10.1074/jbc.R117.783076
   PubMed Web of Science ®Google Scholar
• Hammock BD, Wang W, Gilligan MM, Panigrahy D. Eicosanoids: the overlooked storm in coronavirus disease 2019 (COVID-19)? Am J Pathol. 2020;190:1782–1788. doi:10.1016/j.ajpath.2020.06.010
   PubMed Web of Science ®Google Scholar
• Kubala L, Schmelzer KR, Klinke A, et al. Modulation of arachidonic and linoleic acid metabolites in myeloperoxidase-deficient mice during acute inflammation. Free Radic Biol Med. 2010;48(10):1311–1320. PMID: 20156554; PMCID: PMC2856720. doi:10.1016/j.freeradbiomed.2010.02.010
   PubMed Web of Science ®Google Scholar
• Leow JWH, Verma RK, Lim ABH, Fan H, Chan ECY. Atypical kinetics of cytochrome P450 2J2: epoxidation of arachidonic acid and reversible inhibition by xenobiotic inhibitors. Eur J Pharm Sci. 2021;164(105889):105889. doi:10.1016/j.ejps.2021.105889
   PubMed Web of Science ®Google Scholar
• Yu G, Zeng X, Wang H, et al. 14,15-epoxyeicosatrienoic acid suppresses cigarette smoke extract-induced apoptosis in lung epithelial cells by inhibiting endoplasmic reticulum stress. Cell Physiol Biochem. 2015;36(2):474–486. PMID: 25968975. doi:10.1159/000430113
   PubMedGoogle Scholar
• Samokhvalov V, Jamieson KL, Darwesh AM, et al. Deficiency of soluble epoxide hydrolase protects cardiac function impaired by LPS-induced acute inflammation. Front Pharmacol. 2019;9:1572. PMID: 30692927; PMCID: PMC6339940. doi:10.3389/fphar.2018.01572
   PubMed Web of Science ®Google Scholar
• Li PS, Tao W, Yang LQ, Shu YS. Effect of soluble epoxide hydrolase in hyperoxic acute lung injury in mice. Inflammation. 2018;41(3):1065–1072. PMID: 29574653. doi:10.1007/s10753-018-0758-y
   PubMed Web of Science ®Google Scholar
• Liu L-P, Li B, Shuai T-K, Zhu L, Li Y-M. Deletion of soluble epoxide hydrolase attenuates mice hyperoxic acute lung injury. BMC Anesthesiol. 2018;18:48. doi:10.1186/s12871-018-0490-z
   PubMed Web of Science ®Google Scholar
• Huang H, Weng J, Wang M-H. EETs/sEH in diabetes and obesity-induced cardiovascular diseases. Prostaglandins Other Lipid Mediat. 2016;125:80–89. doi:10.1016/j.prostaglandins.2016.05.004
   PubMed Web of Science ®Google Scholar
• Zhou Y, Liu T, Duan JX, et al. Soluble epoxide hydrolase inhibitor attenuates lipopolysaccharide-induced acute lung injury and improves survival in mice. Shock. 2017;47(5):638–645. PMID: 27753791; PMCID: PMC5382142. doi:10.1097/SHK.0000000000000767
   PubMed Web of Science ®Google Scholar
• Tao W, Li P-S, Yang L-Q, Ma Y-B, Ahmad M. Effects of a soluble epoxide hydrolase inhibitor on lipopolysaccharide-induced acute lung injury in mice. PLoS One. 2016;11(e0160359):e0160359. doi:10.1371/journal.pone.0160359
   PubMed Web of Science ®Google Scholar
• Ackermann M, Verleden SE, Kuehnel M, et al. Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in covid-19. N Engl J Med. 2020;383(2):120–128. PMID: 32437596; PMCID: PMC7412750. doi:10.1056/NEJMoa2015432
   PubMed Web of Science ®Google Scholar
• Hu J, Dziumbla S, Lin J, et al. Inhibition of soluble epoxide hydrolase prevents diabetic retinopathy. Nature. 2017;552(7684):248–252. PMID: 29211719; PMCID: PMC5828869. doi:10.1038/nature25013
   PubMed Web of Science ®Google Scholar
• Ramon S, Baker SF, Sahler JM, et al. The specialized proresolving mediator 17-HDHA enhances the antibody-mediated immune response against influenza virus: a new class of adjuvant? J Immunol. 2014;193(12):6031–6040. PMID: 25392529; PMCID: PMC4258475. doi:10.4049/jimmunol.1302795
   PubMed Web of Science ®Google Scholar
• Panigrahy D, Gilligan MM, Huang S, et al. Inflammation resolution: a dual-pronged approach to averting cytokine storms in COVID-19? Cancer Metastasis Rev. 2020;39(2):337–340. PMID: 32385712; PMCID: PMC7207990. doi:10.1007/s10555-020-09889-4
   PubMed Web of Science ®Google Scholar
• Serhan CN. Pro-resolving lipid mediators are leads for resolution physiology. Nature. 2014;510:92–101. doi:10.1038/nature13479
   PubMed Web of Science ®Google Scholar
• Zhang Z, Xu D, Li Y, et al. Longitudinal alteration of circulating dendritic cell subsets and its correlation with steroid treatment in patients with severe acute respiratory syndrome. Clin Immunol. 2005;116(3):225–235. PMID: 15964242; PMCID: PMC7106242. doi:10.1016/j.clim.2005.04.015
   PubMed Web of Science ®Google Scholar
• Wu Q, Zhou L, Sun X, et al. Altered lipid metabolism in recovered SARS patients twelve years after infection. Sci Rep. 2017;7(1):9110. PMID: 28831119; PMCID: PMC5567209. doi:10.1038/s41598-017-09536-z
   PubMed Web of Science ®Google Scholar
• Sing C-W, Tan KCB, Wong ICK, Cheung BMY, Cheung C-L. Long-term outcome of short-course high-dose glucocorticoids for Severe Acute Respiratory Syndrome (SARS): a 17-year follow-up in SARS survivors. Clin Infect Dis. 2021;72:1830–1833. doi:10.1093/cid/ciaa992
   PubMed Web of Science ®Google Scholar
• Edalatifard M, Akhtari M, Salehi M, et al. Intravenous methylprednisolone pulse as a treatment for hospitalised severe COVID-19 patients: results from a randomised controlled clinical trial. Eur Respir J. 2020;56(6):2002808. PMID: 32943404; PMCID: PMC7758541. doi:10.1183/13993003.02808-2020
   PubMed Web of Science ®Google Scholar
• RECOVERY Collaborative Group. Dexamethasone in hospitalized patients with covid-19. N Engl J Med. 2021;384:693–704. PMID: 32678530; PMCID: PMC7383595. doi:10.1056/NEJMoa2021436
   PubMed Web of Science ®Google Scholar
• Yang Z, Liu J, Zhou Y, Zhao X, Zhao Q, Liu J. The effect of corticosteroid treatment on patients with coronavirus infection: a systematic review and meta-analysis. J Infect. 2020;81(1):e13–e20. PMID: 32283144; PMCID: PMC7195158. doi:10.1016/j.jinf.2020.03.062
   PubMed Web of Science ®Google Scholar
• Oz M, Lorke DE, Kabbani N. A comprehensive guide to the pharmacologic regulation of angiotensin converting enzyme 2 (ACE2), the SARS-CoV-2 entry receptor. Pharmacol Ther. 2021;221:107750. doi:10.1016/j.pharmthera.2020.107750
   PubMed Web of Science ®Google Scholar
• Hoxha M. What about COVID-19 and arachidonic acid pathway? Eur J Clin Pharmacol. 2020;76:1501–1504. doi:10.1007/s00228-020-02941-w
   PubMed Web of Science ®Google Scholar
• Mahesh G, Anil Kumar K, Reddanna P. Overview on the discovery and development of anti-inflammatory drugs: should the focus be on synthesis or degradation of PGE? J Inflamm Res. 2021;14:253–263. doi:10.2147/JIR.S278514
   PubMed Web of Science ®Google Scholar
• Park JH, Park EB, Lee JY, Min JY. Identification of novel membrane-associated prostaglandin E synthase-1 (mPGES-1) inhibitors with anti-influenza activities in vitro. Biochem Biophys Res Commun. 2016;469(4):848–855. PMID: 26673392. doi:10.1016/j.bbrc.2015.11.129
   PubMed Web of Science ®Google Scholar
• Ackermann M, Verleden SE, Kuehnel M, et al. Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in covid-19. N Engl J Med. 2020;383(2):120–128. PMID: 32437596; PMCID: PMC7412750. doi:10.1056/NEJMoa2015432
   PubMed Web of Science ®Google Scholar
• Hu J, Dziumbla S, Lin J, et al. Inhibition of soluble epoxide hydrolase prevents diabetic retinopathy. Nature. 2017;552(7684):248–252. PMID: 29211719; PMCID: PMC5828869. doi:10.1038/nature25013
   PubMed Web of Science ®Google Scholar
• Ramon S, Baker SF, Sahler JM, et al. The specialized proresolving mediator 17-HDHA enhances the antibody-mediated immune response against influenza virus: a new class of adjuvant? J Immunol. 2014;193(12):6031–6040. PMID: 25392529; PMCID: PMC4258475. doi:10.4049/jimmunol.1302795
   PubMed Web of Science ®Google Scholar
• Mainous AG 3rd, Rooks BJ, Velyn W, Orlando FA. COVID-19 post-acute sequelae among adults: 12 month mortality risk. Front Med. 2021;8(December):778434.
   Web of Science ®Google Scholar